Framingham Heart Study: JACC Focus Seminar, 1/8

J Am Coll Cardiol. 2021 Jun 1;77(21):2680-2692. doi: 10.1016/j.jacc.2021.01.059.


The Framingham Heart Study is the longest-running cardiovascular epidemiological study, starting in 1948. This paper gives an overview of the various cohorts, collected data, and most important research findings to date. In brief, the Framingham Heart Study, funded by the National Institutes of Health and managed by Boston University, spans 3 generations of well phenotyped White persons and 2 cohorts comprised of racial and ethnic minority groups. These cohorts are densely phenotyped, with extensive longitudinal follow-up, and they continue to provide us with important information on human cardiovascular and noncardiovascular physiology over the lifespan, as well as to identify major risk factors for cardiovascular disease. This paper also summarizes some of the more recent progress in molecular epidemiology and discusses the future of the study.

Keywords: Framingham Heart Study; cardiovascular epidemiology; molecular epidemiology; risk factors.

Publication types

  • Historical Article
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiology / history*
  • Coronary Disease / epidemiology*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Longitudinal Studies*
  • Massachusetts / epidemiology